Axa’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
+13,452
| New | +$424K | ﹤0.01% | 1004 |
|
|
2021
Q1 | – | Sell |
-8,900
| Closed | -$224K | – | 1329 |
|
|
2020
Q4 | $224K | Buy |
+8,900
| New | +$224K | ﹤0.01% | 1164 |
|
|
2019
Q4 | – | Sell |
-188,446
| Closed | -$5.18M | – | 1308 |
|
|
2019
Q3 | $5.18M | Sell |
188,446
-6,767
| -3% | -$186K | 0.02% | 641 |
|
|
2019
Q2 | $6.46M | Buy |
195,213
+14,835
| +8% | +$491K | 0.03% | 576 |
|
|
2019
Q1 | $6.32M | Buy |
180,378
+31,255
| +21% | +$1.1M | 0.02% | 575 |
|
|
2018
Q4 | $4.95M | Buy |
149,123
+22,604
| +18% | +$751K | 0.02% | 607 |
|
|
2018
Q3 | $6.37M | Buy |
126,519
+124
| +0.1% | +$6.24K | 0.02% | 605 |
|
|
2018
Q2 | $7.57M | Sell |
126,395
-60,056
| -32% | -$3.59M | 0.03% | 535 |
|
|
2018
Q1 | $8.54M | Sell |
186,451
-2,597
| -1% | -$119K | 0.03% | 496 |
|
|
2017
Q4 | $7.53M | Hold |
189,048
| – | – | 0.03% | 556 |
|
|
2017
Q3 | $7.56M | Sell |
189,048
-25,621
| -12% | -$1.02M | 0.03% | 519 |
|
|
2017
Q2 | $9.25M | Buy |
214,669
+6,399
| +3% | +$276K | 0.04% | 440 |
|
|
2017
Q1 | $6.52M | Buy |
+208,270
| New | +$6.52M | 0.03% | 542 |
|
|
2016
Q1 | – | Sell |
-30,500
| Closed | -$410K | – | 1407 |
|
|
2015
Q4 | $410K | Buy |
+30,500
| New | +$410K | ﹤0.01% | 1065 |
|